Medical insurance for fibroid treatment

Medical insurance for fibroid treatment refers to health plans that cover diagnosis, management, and surgical or non-surgical removal of uterine fibroids. Most major US insurers like UnitedHealthcare and Blue Cross Blue Shield include coverage for medically necessary fibroid procedures such as myomectomy, hysterectomy, or uterine artery embolization if documented by a physician.

Policies typically require pre-authorization before approving advanced treatments; Aetna’s 2024 policy mandates prior approval for MRI-guided focused ultrasound surgery. Insurers often exclude elective or cosmetic procedures related to fibroids from coverage, as seen in Cigna’s exclusions list.

Out-of-pocket costs vary: the average deductible for employer-sponsored plans was $1,735 in 2023 (KFF), and copays can range from $20-$50 per specialist visit. Medicaid covers fibroid treatment when deemed medically necessary by a provider; examples include Texas Medicaid paying for inpatient myomectomy with supporting documentation.

Marketplace plans under the ACA must cover essential benefits including hospitalization and surgery but may differ on which specific treatments qualify as essential, as stated by YourInsurance.info (Your Insurance Info). Coverage limitations frequently apply to newer technologies–UnitedHealthcare restricts MRgFUS unless other options fail first.

Appeals are possible if claims are denied; patients have overturned denials by submitting additional clinical evidence showing severe symptoms or failed conservative therapy.